Abstract
Atrial fibrillation (AF) and heart failure (HF) have similar risk factors, frequently coexist, and potentiate each other in a vicious cycle. Evidence suggests the presence of AF in both HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF) increases the risk of all-cause mortality and stroke, particularly when AF is incident. Catheter ablation may be an effective strategy in controlling symptoms and improving quality of life in AF-HFrEF. Strong data guiding management of AF-HFpEF are lacking largely due to its challenging diagnosis. Improving outcomes associated with these coexistent conditions requires further careful investigation.
Original language | English |
---|---|
Pages (from-to) | 47-62 |
Number of pages | 16 |
Journal | Cardiac Electrophysiology Clinics |
Volume | 13 |
Issue number | 1 |
DOIs | |
Publication status | Published or Issued - Mar 2021 |
Externally published | Yes |
Keywords
- Atrial fibrillation
- Heart failure (HF)
- Heart failure with preserved ejection fraction (HFpEF)
- Heart failure with reduced ejection fraction (HFrEF)
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)